PI3K is an intracellular phosphatidylinositol kinase associated with products of oncogenes such as Src and RAS. The PI3K signaling pathway is one of the most frequently activated signaling pathways in human cancer, mediating almost 50% of the occurrence of malignant tumors. Research has shown that excessive activity of the PI3K signaling pathway is significantly correlated with tumor progression, increased tumor microvascular density, and enhanced chemotaxis and invasiveness of cancer cells. At present, PI3K has become an important target for the treatment of various malignant tumors, including breast cancer and follicular lymphoma.
May 28,2024
FDC's Labor Day Shipping Arrangements
April 24,2024
FDC's Qingming Festival shipping arrangement
April 3,2024
This study suggests that excessive APAP can impair TFEB and TFEB mediated lysosomal biogenesis in mouse liver. The gene manipulation of TFEB in mouse liver showed that TFEB has a protective effect on AILI.
March 27,2024
Small cell lung cancer (SCLC) is a highly invasive lung tumor, especially in heavy smokers. Due to its rapid spread, most patients can only be treated with chemotherapy, and its initial anti-tumor effect is very significant. However, as treatment progresses, patients often experience recurrence.
March 21,2024
Women's Day | FDC pays tribute to every shining "she"!
March 8,2024
FDC Wish you a Good Start at the Year of the Dragon
February 18,2024
FDC wish you a happy new year
January 25,2024
